Report Detail

Request for Sample of this report

Pharma & Healthcare Global Antidiabetic Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4601465
    • |
  • 20 July, 2024
    • |
  • Global
    • |
  • 118 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Antidiabetic Drug market size was valued at USD 45900 million in 2023 and is forecast to a readjusted size of USD 87040 million by 2030 with a CAGR of 9.6% during review period.
Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of insulin or decreased insulin sensitivity of target cells. The occurrence of type 2 diabetes mellitus is a combination of peripheral insulin resistance and β cell dysfunction. the result of. When diabetes patients undergo diet and exercise therapy and diabetes care education, blood glucose control can still not reach the treatment goals, the need for drug treatment-Antidiabetic Drug
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Antidiabetic Drug industry chain, the market status of Type I Diabetes (Alpha-Glucosidase Inhibitors, Biguanides, Sulphonylureas), Type II Diabetes (Alpha-Glucosidase Inhibitors, Biguanides, Sulphonylureas), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Antidiabetic Drug.
Regionally, the report analyzes the Antidiabetic Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Antidiabetic Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Antidiabetic Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Antidiabetic Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Alpha-Glucosidase Inhibitors, Biguanides, Sulphonylureas).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Antidiabetic Drug market.
Regional Analysis: The report involves examining the Antidiabetic Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Antidiabetic Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Antidiabetic Drug:
Company Analysis: Report covers individual Antidiabetic Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Antidiabetic Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Type I Diabetes, Type II Diabetes).
Technology Analysis: Report covers specific technologies relevant to Antidiabetic Drug. It assesses the current state, advancements, and potential future developments in Antidiabetic Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Antidiabetic Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Antidiabetic Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Alpha-Glucosidase Inhibitors
Biguanides, Sulphonylureas
Glp-1 Agonist
Meglitinides
Dpp-4 Inhibitors
Sglt–2
Thiazolodinediones
Market segment by Application
Type I Diabetes
Type II Diabetes
Major players covered
Sanofi-Aventis
Eli Lilly
Oramed
Takeda
Boehringer Ingelheim
Novo Nordisk
Halozyme Therapeutics
Bristol-Myers Squibb
Pfizer
Tonghua Dongbao
Biocon
Wockhardt
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antidiabetic Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Antidiabetic Drug, with price, sales, revenue and global market share of Antidiabetic Drug from 2019 to 2024.
Chapter 3, the Antidiabetic Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antidiabetic Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Antidiabetic Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Antidiabetic Drug.
Chapter 14 and 15, to describe Antidiabetic Drug sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Antidiabetic Drug
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Antidiabetic Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Alpha-Glucosidase Inhibitors
    • 1.3.3 Biguanides, Sulphonylureas
    • 1.3.4 Glp-1 Agonist
    • 1.3.5 Meglitinides
    • 1.3.6 Dpp-4 Inhibitors
    • 1.3.7 Sglt–2
    • 1.3.8 Thiazolodinediones
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Antidiabetic Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Type I Diabetes
    • 1.4.3 Type II Diabetes
  • 1.5 Global Antidiabetic Drug Market Size & Forecast
    • 1.5.1 Global Antidiabetic Drug Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Antidiabetic Drug Sales Quantity (2019-2030)
    • 1.5.3 Global Antidiabetic Drug Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Sanofi-Aventis
    • 2.1.1 Sanofi-Aventis Details
    • 2.1.2 Sanofi-Aventis Major Business
    • 2.1.3 Sanofi-Aventis Antidiabetic Drug Product and Services
    • 2.1.4 Sanofi-Aventis Antidiabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Sanofi-Aventis Recent Developments/Updates
  • 2.2 Eli Lilly
    • 2.2.1 Eli Lilly Details
    • 2.2.2 Eli Lilly Major Business
    • 2.2.3 Eli Lilly Antidiabetic Drug Product and Services
    • 2.2.4 Eli Lilly Antidiabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Eli Lilly Recent Developments/Updates
  • 2.3 Oramed
    • 2.3.1 Oramed Details
    • 2.3.2 Oramed Major Business
    • 2.3.3 Oramed Antidiabetic Drug Product and Services
    • 2.3.4 Oramed Antidiabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Oramed Recent Developments/Updates
  • 2.4 Takeda
    • 2.4.1 Takeda Details
    • 2.4.2 Takeda Major Business
    • 2.4.3 Takeda Antidiabetic Drug Product and Services
    • 2.4.4 Takeda Antidiabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Takeda Recent Developments/Updates
  • 2.5 Boehringer Ingelheim
    • 2.5.1 Boehringer Ingelheim Details
    • 2.5.2 Boehringer Ingelheim Major Business
    • 2.5.3 Boehringer Ingelheim Antidiabetic Drug Product and Services
    • 2.5.4 Boehringer Ingelheim Antidiabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Boehringer Ingelheim Recent Developments/Updates
  • 2.6 Novo Nordisk
    • 2.6.1 Novo Nordisk Details
    • 2.6.2 Novo Nordisk Major Business
    • 2.6.3 Novo Nordisk Antidiabetic Drug Product and Services
    • 2.6.4 Novo Nordisk Antidiabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Novo Nordisk Recent Developments/Updates
  • 2.7 Halozyme Therapeutics
    • 2.7.1 Halozyme Therapeutics Details
    • 2.7.2 Halozyme Therapeutics Major Business
    • 2.7.3 Halozyme Therapeutics Antidiabetic Drug Product and Services
    • 2.7.4 Halozyme Therapeutics Antidiabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Halozyme Therapeutics Recent Developments/Updates
  • 2.8 Bristol-Myers Squibb
    • 2.8.1 Bristol-Myers Squibb Details
    • 2.8.2 Bristol-Myers Squibb Major Business
    • 2.8.3 Bristol-Myers Squibb Antidiabetic Drug Product and Services
    • 2.8.4 Bristol-Myers Squibb Antidiabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Bristol-Myers Squibb Recent Developments/Updates
  • 2.9 Pfizer
    • 2.9.1 Pfizer Details
    • 2.9.2 Pfizer Major Business
    • 2.9.3 Pfizer Antidiabetic Drug Product and Services
    • 2.9.4 Pfizer Antidiabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Pfizer Recent Developments/Updates
  • 2.10 Tonghua Dongbao
    • 2.10.1 Tonghua Dongbao Details
    • 2.10.2 Tonghua Dongbao Major Business
    • 2.10.3 Tonghua Dongbao Antidiabetic Drug Product and Services
    • 2.10.4 Tonghua Dongbao Antidiabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Tonghua Dongbao Recent Developments/Updates
  • 2.11 Biocon
    • 2.11.1 Biocon Details
    • 2.11.2 Biocon Major Business
    • 2.11.3 Biocon Antidiabetic Drug Product and Services
    • 2.11.4 Biocon Antidiabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Biocon Recent Developments/Updates
  • 2.12 Wockhardt
    • 2.12.1 Wockhardt Details
    • 2.12.2 Wockhardt Major Business
    • 2.12.3 Wockhardt Antidiabetic Drug Product and Services
    • 2.12.4 Wockhardt Antidiabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Wockhardt Recent Developments/Updates

3 Competitive Environment: Antidiabetic Drug by Manufacturer

  • 3.1 Global Antidiabetic Drug Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Antidiabetic Drug Revenue by Manufacturer (2019-2024)
  • 3.3 Global Antidiabetic Drug Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Antidiabetic Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Antidiabetic Drug Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Antidiabetic Drug Manufacturer Market Share in 2023
  • 3.5 Antidiabetic Drug Market: Overall Company Footprint Analysis
    • 3.5.1 Antidiabetic Drug Market: Region Footprint
    • 3.5.2 Antidiabetic Drug Market: Company Product Type Footprint
    • 3.5.3 Antidiabetic Drug Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Antidiabetic Drug Market Size by Region
    • 4.1.1 Global Antidiabetic Drug Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Antidiabetic Drug Consumption Value by Region (2019-2030)
    • 4.1.3 Global Antidiabetic Drug Average Price by Region (2019-2030)
  • 4.2 North America Antidiabetic Drug Consumption Value (2019-2030)
  • 4.3 Europe Antidiabetic Drug Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Antidiabetic Drug Consumption Value (2019-2030)
  • 4.5 South America Antidiabetic Drug Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Antidiabetic Drug Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Antidiabetic Drug Sales Quantity by Type (2019-2030)
  • 5.2 Global Antidiabetic Drug Consumption Value by Type (2019-2030)
  • 5.3 Global Antidiabetic Drug Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Antidiabetic Drug Sales Quantity by Application (2019-2030)
  • 6.2 Global Antidiabetic Drug Consumption Value by Application (2019-2030)
  • 6.3 Global Antidiabetic Drug Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Antidiabetic Drug Sales Quantity by Type (2019-2030)
  • 7.2 North America Antidiabetic Drug Sales Quantity by Application (2019-2030)
  • 7.3 North America Antidiabetic Drug Market Size by Country
    • 7.3.1 North America Antidiabetic Drug Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Antidiabetic Drug Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Antidiabetic Drug Sales Quantity by Type (2019-2030)
  • 8.2 Europe Antidiabetic Drug Sales Quantity by Application (2019-2030)
  • 8.3 Europe Antidiabetic Drug Market Size by Country
    • 8.3.1 Europe Antidiabetic Drug Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Antidiabetic Drug Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Antidiabetic Drug Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Antidiabetic Drug Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Antidiabetic Drug Market Size by Region
    • 9.3.1 Asia-Pacific Antidiabetic Drug Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Antidiabetic Drug Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Antidiabetic Drug Sales Quantity by Type (2019-2030)
  • 10.2 South America Antidiabetic Drug Sales Quantity by Application (2019-2030)
  • 10.3 South America Antidiabetic Drug Market Size by Country
    • 10.3.1 South America Antidiabetic Drug Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Antidiabetic Drug Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Antidiabetic Drug Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Antidiabetic Drug Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Antidiabetic Drug Market Size by Country
    • 11.3.1 Middle East & Africa Antidiabetic Drug Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Antidiabetic Drug Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Antidiabetic Drug Market Drivers
  • 12.2 Antidiabetic Drug Market Restraints
  • 12.3 Antidiabetic Drug Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Antidiabetic Drug and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Antidiabetic Drug
  • 13.3 Antidiabetic Drug Production Process
  • 13.4 Antidiabetic Drug Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Antidiabetic Drug Typical Distributors
  • 14.3 Antidiabetic Drug Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Antidiabetic Drug. Industry analysis & Market Report on Antidiabetic Drug is a syndicated market report, published as Global Antidiabetic Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Antidiabetic Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,683.08
    		4,024.62
    		5,366.16
    		3,208.56
    		4,812.84
    		6,417.12
    		533,240.40
    		799,860.60
    		1,066,480.80
    		292,702.80
    		439,054.20
    		585,405.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo